Inventaire - your friends and communities are your best library - Inventaire

The Role of Neuropeptides in Mouse Models of Colitis

author

David M. Padua

published in: Journal of Molecular Neuroscience

date of publication: 2015-12-08

language: English

main subject: colitis

Cites articles 74

Date

Title

Authors

2015-06-01

Next-Generation Therapeutics for IBD
2015-05-01

Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice

Alison Buchan, Oana-Eugenia Popescu, William T. Gibson, Kevan Jacobson
2015-06-01

Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease
2014-10-03

Vasoactive intestinal peptide-deficient mice exhibit reduced pathology in trinitrobenzene sulfonic acid-induced colitis
2014-05-27

Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease

Yava Jones-Hall
2014-01-07

Inhibition of vasoactive intestinal polypeptide (VIP) induces resistance to dextran sodium sulfate (DSS)-induced colitis in mice

Mulugeta Million, Muriel Larauche
2013-08-01

Tumor necrosis factor inhibitors for inflammatory bowel disease

Ole Haagen Nielsen, Mark A Ainsworth
2012-05-14

Dextran sodium sulphate colitis mouse model: traps and tricks
2012-09-20

TGFβ signalling in context

Joan Massagué Solé
2012-11-01

Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach

Tamas Bartfai, Daniel Hoyer
2012-10-01

Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel disease
2012-04-24

Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in mice

Daniel J. Drucker
2012-05-01

Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Victor May
2011-02-10

Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies
2011-04-26

Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease

Frédéric Rieux-Laucat, Jean-Pierre Hugot, Bernadette Begue, Julien Verdier, Bénédicte Pigneur, Nadine Cerf-Bensussan
2011-01-07

VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis

Edward J Goetzl
2010-10-01

Increased apoptosis and decreased proliferation of colonic epithelium in dextran sulfate sodium-induced colitis in mice
2009-11-19

Inflammatory bowel disease,炎症性肠病
2009-11-04

Inflammatory bowel disease and mutations affecting the interleukin-10 receptor

Ulrich Salzer, Anthony Segal, Bodo Grimbacher, Alejandro A Schäffer
2009-05-14

Neurotensin induces IL-6 secretion in mouse preadipocytes and adipose tissues during 2,4,6,-trinitrobenzensulphonic acid-induced colitis
2009-03-01

Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis
2009-03-12

Transforming growth factor-beta1 and its receptors in patients with ulcerative colitis

Grzegorz Machnik, Krzysztof Łabuzek
2008-02-01

Ameliorative effects of bombesin and neurotensin on trinitrobenzene sulphonic acid-induced colitis, oxidative damage and apoptosis in rats
2008-10

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease

William Jeffery Sandborn, Brian G. Feagan, Paul Rutgeerts, Richard N. Fedorak, Ellen J Scherl, Seymour Katz
2007-02-01

Pituitary adenylate cyclase-activating polypeptide: a novel peptide with protean implications
2007-05-18

Gastrointestinal dysfunction in mice with a targeted mutation in the gene encoding vasoactive intestinal polypeptide: a model for the study of intestinal ileus and Hirschsprung's disease

Pierre Gressens, Géraldine Favrais, Catalina Abad, Vincent Lelievre
2007-01-01

Chemically induced mouse models of intestinal inflammation

Stefan Wirtz, Benno Weigmann, Markus Neurath, Clemens Neufert
2006-08-01

Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation

Fiona Powrie
2006-09-19

Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis
2006-10-31

Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis
2005-12-08

Infliximab for induction and maintenance therapy for ulcerative colitis

Paul Rutgeerts, William Jeffery Sandborn, Brian G. Feagan, Jean-Frédéric Colombel, Bruce E. Sands, Gary R Lichtenstein, Walter Reinisch, Stephen B Hanauer, Daniel Rachmilewitz
2005-04-01

Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation

Luisa Barzon, Giorgio Palù, Ignazio Castagliuolo

Article - wd:Q26773507

Welcome to Inventaire

the library of your friends and communities

you are offline